APTOF - Aptose Biosciences Inc
1.6117
-0.024 -1.508%
Share volume: 9,327
Last Updated: 03-27-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$1.64
-0.02
-0.01%
View ratios
| Fiscal Date | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-08-2025 | 08-13-2025 | 11-13-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | |||
| Operating expenses | 5.461 M | 6.921 M | 4.913 M | |
| Selling general and admin | 3.097 M | 3.623 M | 2.708 M | |
| Research and development | 2.364 M | 3.298 M | 2.205 M | |
| Total expenses | 5.461 M | 6.921 M | 4.913 M | |
| 26.74% | -29.01% | |||
| Operating income | -5.461 M | -6.921 M | -4.913 M | |
| Ebit | -5.459 M | -6.933 M | -4.911 M | |
| Pretax income | -5.543 M | -7.043 M | -5.123 M | |
| 27.06% | -27.26% | |||
| Income tax | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -5.543 M | -7.043 M | -5.123 M | |
| -27.06% | 27.26% |